bluebird bio
BLUE
#9806
Rank
โ‚ฌ41.71 M
Marketcap
4,26ย โ‚ฌ
Share price
0.00%
Change (1 day)
-77.96%
Change (1 year)

Earnings for bluebird bio (BLUE)

Earnings in 2025 (TTM): -โ‚ฌ0.19 Billion

According to bluebird bio 's latest financial reports the company's current earnings are โ‚ฌ0.10 Billion. In 2024 the company made an earning of -โ‚ฌ0.21 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.19 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for bluebird bio from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.19 Billion-10.45%
2024 -โ‚ฌ0.21 Billion9.52%
2023 -โ‚ฌ0.19 Billion-17.54%
2022 -โ‚ฌ0.23 Billion-18.85%
2021 -โ‚ฌ0.29 Billion-46.87%
2020 -โ‚ฌ0.53 Billion-21.79%
2019 -โ‚ฌ0.68 Billion42.26%
2018 -โ‚ฌ0.48 Billion65.59%
2017 -โ‚ฌ0.29 Billion27%
2016 -โ‚ฌ0.23 Billion58.42%
2015 -โ‚ฌ0.15 Billion175.54%
2014 -โ‚ฌ51.87 Million138.96%
2013 -โ‚ฌ21.71 Million6.98%
2012 -โ‚ฌ20.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.58 B-439.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-โ‚ฌ0.22 Billion 27.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.80 B-4,654.41%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-โ‚ฌ93.46 Million-45.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.79 B-11,655.86%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚ฌ25.28 Million-85.24%๐Ÿ‡บ๐Ÿ‡ธ USA